Home » Healthcare » Pharmaceuticals » Poultry Vaccines Market

Poultry Vaccines Market By Application (Broiler, Layer and Breeder), By Product (Attenuated Live Vaccines, Broiler, Lay Vaccines, Subunit Vaccines, DNA Vaccines and Recombinant Vaccines) Growth, Future Prospects & Competitive Analysis, 2016 – 2030

Summary
Table Of Content

Key Highlights of the report

How are the major segments performing in the poultry vaccines market?

In 2022, the breeder category accounted for the largest market share due to the rise of breeder farms that produce fertile eggs hatched in an incubator.
In 2022, the attenuated live vaccines category held the largest share. Compared to other immunizations, these vaccines can cause the immune system to manufacture more antibodies.
In 2022, the infectious bronchitis category held the largest share due to the increased prevalence of bronchitis. Poultry animals are susceptible to infectious bronchitis, a frequent and contagious illness. It has a high morbidity rate and is quite prevalent.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

What is the market size of poultry vaccines regarding value?

The global poultry vaccines market is anticipated to grow at a substantial CAGR of 7.30% in the upcoming years. The global Poultry vaccines industry was estimated to be worth USD 2.1 billion in 2022 and was expected to be worth USD 3.4 billion by 2028.

Which region dominated the poultry vaccines market?

In 2022, the North American region was anticipated to hold a prominent share of the global poultry vaccines market due to several causes, including the rise in the consumption of products made from chicken, increased consumer knowledge of food safety, and an increase in the prevalence of zoonotic diseases linked to poultry. The increase in this region’s population is also attributed to increased egg production, rising consumer concern over food safety, rising consumption of products derived from poultry, an increase in zoonotic diseases linked to poultry, and an increase in vaccine development, including the creation of live gene-deleted vaccines, non-replicating recombinant antigen vaccines, live vector vaccines, and nucleic acid-mediated vaccines.

How US market is performing in the poultry vaccines market?

In 2022, the United States was anticipated to hold a prominent share in the global poultry vaccines market in the North American region due to the consumption of chicken products and growing knowledge about the safety of poultry food as a result of people’s high standard of living. The USDA estimates that Americans consumed roughly 65.2 pounds of chicken per person in 2018. Around 17% of the world’s broiler chicken production and almost 42.5 million pounds of chicken products are consumed in the United States, according to the national chicken council. Improved living standards will also increase consumer knowledge of poultry food’s safety, fueling market expansion. The main source of animal protein is poultry. The United States is the world’s biggest producer of poultry meat.

How is the economy impacting the global poultry vaccines growth?

The economy has a complicated and wide-ranging effect on the worldwide poultry vaccination market. Recessions and other periods of economic uncertainty can harm the sector. For instance, during times of financial difficulty or uncertainty, consumers may cut back on their meat intake, resulting in a decline in the market for poultry and, in turn, a decline in the need for vaccines. Moreover, economic difficulties may make it more difficult for chicken producers to invest in preventive measures like immunizations, which may impede the industry’s growth. Another thing to consider is the COVID-19 pandemic’s effects on the vaccine market and poultry sector. The poultry vaccination industry has also been impacted by the pandemic’s disruption of supply chains and price volatility.

What is the competitive environment of the poultry vaccines market?

Many major players are active in the fiercely competitive global market for poultry vaccinations. These participants range from major international organizations to smaller businesses and local players. Probiotics, antibodies, and RNA vaccines are becoming more popular as viable alternatives to conventional vaccines, and there is rising market competition for these alternative in addition to conventional vaccines. Generally, the poultry vaccines market is highly competitive, with several important manufacturers striving for market dominance and spending money on R&D to keep one step ahead of their rivals. For instance, in August 2022, Afrivet was purchased by Bimeda for an undisclosed sum. Bimeda is an Irish developer, producer, and marketer of veterinary pharmaceuticals and animal care products. Bimeda will have the largest geographic presence among animal health companies in Africa after this acquisition. The manufacturer of chicken vaccinations located in South Africa is Afrivet.

Executive Summary

What are the key trends in the poultry vaccines market?

Rising prevalence of zoonotic diseases: The market for poultry vaccines is anticipated to develop due to the rising prevalence of zoonotic illnesses. A group of common conditions known as zoonotic diseases are caused by pathogenic microorganisms like fungi, bacteria, viruses, and parasites. The threat of zoonotic diseases is increased by significant changes in land use, urbanization, and natural habitat degradation. These factors have all been linked to disease onset by increasing human-animal encounters and hastening transmission rates. There is a rise in demand for chicken vaccinations due to the spike in zoonotic infections. For instance, the number of zoonotic cases in Africa increased by 64% in July 2022, according to a report published by the world health organization, a US government institution. Furthermore, both globally and in India, zoonotic diseases are spreading more widely. Eighty-six percent of the 1407 human pathogens—or 816—are zoonotic pathogens, which cause infectious diseases in people. Hence, it is anticipated that the rising incidence of zoonotic illnesses will fuel the demand for poultry vaccinations.

How has advanced technology influenced the market for poultry vaccines?

A prominent factor gaining prominence in the poultry vaccines market is technological developments in poultry vaccinations. Thanks to innovation and technology, vaccines are now the most effective and economical means of preventing illness in poultry animals. Major players in the poultry vaccination market are concentrating on creating innovative technological solutions to improve their position. For instance, the VAXXITEK HVT+IBD+ND vaccine was introduced by the German pharmaceutical company Boehringer Ingelheim in January 2020 to safeguard poultry against three diseases. The immune system is strengthened with VAXXITEK ® HVT+IBD+ND, which also offers improved defenses against Newcastle disease, infectious bursal disease, and Marek’s disease.

Which are the key investments by the poultry vaccines market players?

The major investments made by poultry vaccine market participants differ depending on their business strategy and priorities. Many companies invest heavily in R&D to develop new and innovative vaccines that protect poultry from diseases. This strategy includes investments in genomics, biotechnology, and molecular biology to develop more effective vaccines. Furthermore, companies may acquire or merge with other companies to diversify their product portfolio, increase their market share, or gain access to new markets.

Some major players in the poultry vaccines market are Boehringer Ingelheim International GmbH; Ceva; Zoetis; Elanco; Intervet Inc., a Subsdiairy of Merck & Co., Inc.; Hester Biosciences Limited; Vaxxinova International BV; Venkys India; Calier; KM Biologics and Phibro Animal Health Corporation.

What are the major driving factors for the poultry vaccines market?

Global zoonotic disease incidence is expected to rise, propelling market expansion. The market is also growing due to expanding government initiative activities and rising public awareness of poultry vaccines. Furthermore, the market can expand due to the rapidly growing poultry population. Increasing consumer demand for food products generated from chicken and vaccines for poultry presents enormous opportunities to market participants, and this demand is anticipated to fuel the market’s profitable expansion. The introduction of live, nucleic acid-mediated, non-replicating recombinant antigens, live-gene detected vaccines, a significant increase in animal health spending globally, and an increase in the poultry population, and these factors are all expected to have a significant impact on the market.

What are the major risks for the poultry vaccines market?

Several market restrictions may impact the market for poultry vaccinations. The high vaccine development, production, and distribution expense is a significant barrier. Lack of knowledge and instruction among chicken farmers regarding the significance of vaccinations is another market restraint. Moreover, introducing substitute protein sources, such as plant meat, may decrease the demand for poultry products, including vaccinations. Finally, significant market restraints may also result from the outbreak of novel diseases or the evolution of existing diseases.

Which is the key application category in the poultry vaccines market?

The breeder category held the largest market share in 2022 due to the rise of breeder farms that produce fertile eggs that are then hatched in an incubator. The market has expanded because of these breeding facilities’ increased output. The market expansion can also be due to numerous government programs that protect vaccinated birds and their offspring by requiring breeders to receive vaccinations. Breeder farms have expanded due to proactive government initiatives that have led to an increase in the number of feed mills, breeders, and poultry integrators.

How is the poultry vaccines market performing in regions?

During the forecast period, the Asia Pacific market is anticipated to witness the fastest growth in the global poultry vaccines market because of government programs to vaccinate birds and increase poultry output. Various government immunization programs are stimulating the market for chickens. There are systematic immunization programs for diseases such as avian encephalomyelitis, Newcastle disease, Marek’s disease, etc., across most Asian nations. To prevent most infectious illnesses, developed poultry companies adopt onsite biosecurity measures that veterinarians closely monitor. With 64% of the world’s production of eggs coming from Asia, this continent produces the most of them. China produces 37% of the world’s eggs, followed by India with 6%, according to fao.org.

What is the regulatory landscape for the poultry vaccines market?

The safety and effectiveness of poultry vaccinations are ensured in large part by regulatory organizations, and it is necessary for businesses engaged in the poultry vaccine market to adhere to these standards. For instance, the United States Department of Agriculture (USDA), which manages the Center for Veterinary Biologics, is the regulatory body responsible for the clearance of chicken vaccinations in the country (CVB). Veterinary biologics, including vaccinations, are subject to regulation by the CVB concerning their production, testing, and distribution in the country. In contrast, the European Medicines Agency (EMA) is in charge of approving veterinary vaccines, including those for poultry, throughout that continent. The EMA establishes regulations and manages the approval procedure for the quality, safety, and effectiveness of veterinary vaccinations.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

What are the major players planning for the future of the poultry vaccines market?

The need for poultry products, the prevalence of numerous poultry diseases, and the growing understanding of the advantages of vaccination are all projected to contribute to the poultry vaccine market’s significant rise during the upcoming years. Developing novel and cutting-edge vaccinations to prevent and control numerous diseases afflicting poultry was a top priority for major participants in the poultry vaccine industry. This would enable them to meet the growing need for effective and efficient vaccines while expanding their product line. In order to create new vaccines and broaden their market reach, several businesses were also concentrating on establishing strategic alliances and partnerships with other businesses and research institutions.

REPORT ATTRIBUTE	DETAILS
Poultry Vaccines Market by Volume	Yes
Poultry Vaccines Market by Value	Yes
Poultry Vaccines Market, Tornado Analysis	Yes
Poultry Vaccines Market, STAR Analysis	Yes
Poultry Vaccines Market, SRC Analysis	Yes
Poultry Vaccines Market, Import-Export Data	Yes (On Demand)
Poultry Vaccines Market Pricing Analysis	Yes (On Demand)
Poultry Vaccines Market Segment Analysis	By Application (Broiler, Layer and Breeder) By Product (Attenuated Live Vaccines, Broiler, Lay Vaccines, Subunit Vaccines, DNA Vaccines and Recombinant Vaccines) By Disease Type (Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus, Duck Viral Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek’s Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis and Fowl Cholera)
Poultry Vaccines Market, Regional Analysis	North America (US and Canada) Europe (Germany, UK, France, Italy, Spain, and Rest of Europe) Asia Pacific (China, India, Japan, South Korea, South East Asia, and Rest of Asia Pacific) Latin America (Brazil, Mexico, and Rest of Latin America) Middle East and Africa (GCC Countries, South Africa, and Rest of Middle East and Africa)
Poultry Vaccines Market Key Companies	Boehringer Ingelheim International GmbH; Ceva; Zoetis; Elanco; Intervet Inc., a Subsdiairy of Merck & Co., Inc.; Hester Biosciences Limited; Vaxxinova International BV; Venkys India; Calier; KM Biologics and Phibro Animal Health Corporation.
Poultry Vaccines Market Competitive Landscape	Market Share Analysis Competitive Benchmarking Key Players Market Positioning Geographical Presence Analysis Major Strategies Adopted

Segmentation of Global Poultry vaccines Market-

Global Poultry vaccines Market – By Application

Broiler
Layer
Breeder

Global Poultry vaccines Market – By Product

Attenuated Live Vaccines
Broiler
Lay Vaccines
Subunit Vaccines
DNA Vaccines
Recombinant Vaccines

Global Poultry vaccines Market – By Disease Type

Infectious Bronchitis
Infectious Bursal Diseases
Infectious Laryngotracheitis
Egg Drop Syndrome
Adenovirus
Duck Viral Enteritis
Inclusion Body Hepatitis
Coccidiosis
Avian Influenza
Marek’s Disease
Newcastle Disease
Salmonella
Avian Encephalomyelitis
Fowl Cholera

Global Poultry vaccines Market – By Region

North America
- U.S.
- Canada
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- South-east Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East and Africa

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Approach Adopted
1.3.4.1. Top-Down Approach
1.3.4.2. Bottom-Up Approach
1.3.5. Assumptions
1.4. Market Introduction
1.5. Market Research Scope

2. Executive Summary
2.1. Market Snapshot: Global Poultry Vaccines Market
2.2. Global Poultry Vaccines Market, By Application
2.3. Global Poultry Vaccines Market, By Product
2.4. Global Poultry Vaccines Market, By Disease Type
2.5. Global Poultry Vaccines Market, By Region

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Poultry Vaccines Market Value, 2017-2030, (US$ Bn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.2. Market Restraints
3.2.3. Market Opportunities
3.2.4. Major Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Type
3.5.2. Product
3.5.3. Geography

4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Types
4.2.5. Intensity of Competitive Rivalry
4.3. Key Market Trends
4.3.1. Demand Side Trends
4.3.2. Supply Side Trends
4.4. Value Chain Analysis
4.5. Material Analysis
4.6. Analysis and Recommendations
4.7. Marketing Strategy Analysis
4.7.1. Direct Marketing
4.7.2. Indirect Marketing
4.7.3. Marketing Channel Development Trend

5. Market Positioning of Key Players, 2022
5.1. Company market share of key players, 2022
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Product Launch
5.5.5. Geographical Expansion
5.5.6. Others

6. Economic Impact Analysis
6.1. Recession Impact
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Latin America
6.1.5. Middle East and Africa
6.2. Ukraine-Russia War Impact
6.2.1. North America
6.2.2. Europe
6.2.3. Asia Pacific
6.2.4. Latin America
6.2.5. Middle East and Africa
6.3. COVID-19 Impact Analysis
6.3.1. North America
6.3.2. Europe
6.3.3. Asia Pacific
6.3.4. Latin America
6.3.5. Middle East and Africa

7. Global Poultry Vaccines Market
7.1. Global Poultry Vaccines Market, by Application, 2017-2030 (US$ Bn)
7.1.1. Overview
7.1.2. Global Poultry Vaccines Market, By Application, 2022 vs 2030 (in%)
7.1.3. Global Poultry Vaccines Market, By Broiler, 2017-2030 (US$ Bn)
7.1.4. Global Poultry Vaccines Market, By Layer, 2017-2030 (US$ Bn)
7.1.5. Global Poultry Vaccines Market, By Breeder, 2017-2030 (US$ Bn)
7.2. Global Poultry Vaccines Market, by Product, 2017-2030 (US$ Bn)
7.2.1. Overview
7.2.2. Global Poultry Vaccines Market, By Product, 2022 vs 2030 (in%)
7.2.3. Global Poultry Vaccines Market, By Attenuated Live Vaccines, 2017-2030 (US$ Bn)
7.2.4. Global Poultry Vaccines Market, By Broiler, 2017-2030 (US$ Bn)
7.2.5. Global Poultry Vaccines Market, By Lay Vaccines, 2017-2030 (US$ Bn)
7.2.6. Global Poultry Vaccines Market, By Subunit Vaccines, 2017-2030 (US$ Bn)
7.2.7. Global Poultry Vaccines Market, By DNA Vaccines, 2017-2030 (US$ Bn)
7.2.8. Global Poultry Vaccines Market, By Recombinant Vaccines, 2017-2030 (US$ Bn)
7.3. Global Poultry Vaccines Market, by Disease Type, 2017-2030 (US$ Bn)
7.3.1. Overview
7.3.2. Global Poultry Vaccines Market, By Disease Type, 2022 vs 2030 (in%)
7.3.3. Global Poultry Vaccines Market, By Infectious Bronchitis, 2017-2030 (US$ Bn)
7.3.4. Global Poultry Vaccines Market, By Infectious Bursal Diseases, 2017-2030 (US$ Bn)
7.3.5. Global Poultry Vaccines Market, By Infectious Laryngotracheitis, 2017-2030 (US$ Bn)
7.3.6. Global Poultry Vaccines Market, By Egg Drop Syndrome, 2017-2030 (US$ Bn)
7.3.7. Global Poultry Vaccines Market, By Adenovirus, 2017-2030 (US$ Bn)
7.3.8. Global Poultry Vaccines Market, By Duck Viral Enteritis, 2017-2030 (US$ Bn)
7.3.9. Global Poultry Vaccines Market, By Inclusion Body Hepatitis, 2017-2030 (US$ Bn)
7.3.10. Global Poultry Vaccines Market, By Coccidiosis, 2017-2030 (US$ Bn)
7.3.11. Global Poultry Vaccines Market, By Avian Influenza, 2017-2030 (US$ Bn)
7.3.12. Global Poultry Vaccines Market, By Marek’s Disease, 2017-2030 (US$ Bn)
7.3.13. Global Poultry Vaccines Market, By Newcastle Disease, 2017-2030 (US$ Bn)
7.3.14. Global Poultry Vaccines Market, By Salmonella, 2017-2030 (US$ Bn)
7.3.15. Global Poultry Vaccines Market, By Avian Encephalomyelitis, 2017-2030 (US$ Bn)
7.3.16. Global Poultry Vaccines Market, By Fowl Cholera, 2017-2030 (US$ Bn)

8. North America Poultry Vaccines Market Analysis
8.1. North America Poultry Vaccines Market, by Application, 2017-2030(US$ Bn)
8.1.1. Overview
8.1.2. SRC Analysis
8.2. North America Poultry Vaccines Market, by Product, 2017-2030(US$ Bn)
8.2.1. Overview
8.2.2. SRC Analysis
8.3. North America Poultry Vaccines Market, by Disease Type, 2017-2030(US$ Bn)
8.3.1. Overview
8.3.2. SRC Analysis
8.4. North America Poultry Vaccines Market, by Country, 2017-2030 (US$ Bn)
8.4.1. U.S.
8.4.1.1. U.S. Poultry Vaccines Market Estimates and Forecast, 2017-2030 (US$ Bn)
8.4.1.2. U.S. Poultry Vaccines, By Application, 2017-2030 (US$ Bn)
8.4.1.3. U.S. Poultry Vaccines, By Product, 2017-2030 (US$ Bn)
8.4.1.4. U.S. Poultry Vaccines, By Disease Type, 2017-2030 (US$ Bn)
8.4.2. Canada
8.4.2.1. Canada Poultry Vaccines Market Estimates and Forecast, 2017-2030 (US$ Bn)
8.4.2.2. Canada Poultry Vaccines, By Application, 2017-2030 (US$ Bn)
8.4.2.3. Canada Poultry Vaccines, By Product, 2017-2030 (US$ Bn)
8.4.2.4. Canada Poultry Vaccines, By Disease Type, 2017-2030 (US$ Bn)

9. Europe Poultry Vaccines Market Analysis
9.1. Europe Poultry Vaccines Market, by Application, 2017-2030(US$ Bn)
9.1.1. Overview
9.1.2. SRC Analysis
9.2. Europe Poultry Vaccines Market, by Product, 2017-2030(US$ Bn)
9.2.1. Overview
9.2.2. SRC Analysis
9.3. Europe Poultry Vaccines Market, by Disease Type, 2017-2030(US$ Bn)
9.3.1. Overview
9.3.2. SRC Analysis
9.4. Europe Poultry Vaccines Market, by Country, 2017-2030 (US$ Bn)
9.4.1. Germany
9.4.1.1. Germany Poultry Vaccines Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.4.1.2. Germany Poultry Vaccines, By Application, 2017-2030 (US$ Bn)
9.4.1.3. Germany Poultry Vaccines, By Product, 2017-2030 (US$ Bn)
9.4.1.4. Germany Poultry Vaccines, By Disease Type, 2017-2030 (US$ Bn)
9.4.2. France
9.4.2.1. France Poultry Vaccines Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.4.2.2. France Poultry Vaccines, By Application, 2017-2030 (US$ Bn)
9.4.2.3. France Poultry Vaccines, By Product, 2017-2030 (US$ Bn)
9.4.2.4. France Poultry Vaccines, By Disease Type, 2017-2030 (US$ Bn)
9.4.3. UK
9.4.3.1. UK Poultry Vaccines Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.4.3.2. UK Poultry Vaccines, By Application, 2017-2030 (US$ Bn)
9.4.3.3. UK Poultry Vaccines, By Product, 2017-2030 (US$ Bn)
9.4.3.4. UK Poultry Vaccines, By Disease Type, 2017-2030 (US$ Bn)
9.4.4. Italy
9.4.4.1. Italy Poultry Vaccines Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.4.4.2. Italy Poultry Vaccines, By Application, 2017-2030 (US$ Bn)
9.4.4.3. Italy Poultry Vaccines, By Product, 2017-2030 (US$ Bn)
9.4.4.4. Italy Poultry Vaccines, By Disease Type, 2017-2030 (US$ Bn)
9.4.5. Spain
9.4.5.1. Spain Poultry Vaccines Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.4.5.2. Spain Poultry Vaccines, By Application, 2017-2030 (US$ Bn)
9.4.5.3. Spain Poultry Vaccines, By Product, 2017-2030 (US$ Bn)
9.4.5.4. Spain Poultry Vaccines, By Disease Type, 2017-2030 (US$ Bn)
9.4.6. Rest of Europe
9.4.6.1. Rest of Europe Poultry Vaccines Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.4.6.2. Rest of Europe Poultry Vaccines, By Application, 2017-2030 (US$ Bn)
9.4.6.3. Rest of Europe Poultry Vaccines, By Product, 2017-2030 (US$ Bn)
9.4.6.4. Rest of Europe Poultry Vaccines, By Disease Type, 2017-2030 (US$ Bn)

10. Asia Pacific Poultry Vaccines Market Analysis
10.1. Asia Pacific Poultry Vaccines Market, by Application, 2017-2030(US$ Bn)
10.1.1. Overview
10.1.2. SRC Analysis
10.2. Asia Pacific Poultry Vaccines Market, by Product, 2017-2030(US$ Bn)
10.2.1. Overview
10.2.2. SRC Analysis
10.3. Asia Pacific Poultry Vaccines Market, by Disease Type, 2017-2030(US$ Bn)
10.3.1. Overview
10.3.2. SRC Analysis
10.4. Asia Pacific Poultry Vaccines Market, by Country, 2017-2030 (US$ Bn)
10.4.1. China
10.4.1.1. China Poultry Vaccines Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.4.1.2. China Poultry Vaccines, By Application, 2017-2030 (US$ Bn)
10.4.1.3. China Poultry Vaccines, By Product, 2017-2030 (US$ Bn)
10.4.1.4. China Poultry Vaccines, By Disease Type, 2017-2030 (US$ Bn)
10.4.2. Japan
10.4.2.1. Japan Poultry Vaccines Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.4.2.2. Japan Poultry Vaccines, By Application, 2017-2030 (US$ Bn)
10.4.2.3. Japan Poultry Vaccines, By Product, 2017-2030 (US$ Bn)
10.4.2.4. Japan Poultry Vaccines, By Disease Type, 2017-2030 (US$ Bn)
10.4.3. India
10.4.3.1. India Poultry Vaccines Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.4.3.2. India Poultry Vaccines, By Application, 2017-2030 (US$ Bn)
10.4.3.3. India Poultry Vaccines, By Product, 2017-2030 (US$ Bn)
10.4.3.4. India Poultry Vaccines, By Disease Type, 2017-2030 (US$ Bn)
10.4.4. South Korea
10.4.4.1. South Korea Poultry Vaccines Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.4.4.2. South Korea Poultry Vaccines, By Application, 2017-2030 (US$ Bn)
10.4.4.3. South Korea Poultry Vaccines, By Product, 2017-2030 (US$ Bn)
10.4.4.4. South Korea Poultry Vaccines, By Disease Type, 2017-2030 (US$ Bn)
10.4.5. South-East Asia
10.4.5.1. South-East Asia Poultry Vaccines Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.4.5.2. South-East Asia Poultry Vaccines, By Application, 2017-2030 (US$ Bn)
10.4.5.3. South-East Asia Poultry Vaccines, By Product, 2017-2030 (US$ Bn)
10.4.5.4. South-East Asia Poultry Vaccines, By Disease Type, 2017-2030 (US$ Bn)
10.4.6. Rest of Asia Pacific
10.4.6.1. Rest of Asia Pacific Poultry Vaccines Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.4.6.2. Rest of Asia Pacific Poultry Vaccines, By Application, 2017-2030 (US$ Bn)
10.4.6.3. Rest of Asia Pacific Poultry Vaccines, By Product, 2017-2030 (US$ Bn)
10.4.6.4. Rest of Asia Pacific Poultry Vaccines, By Disease Type, 2017-2030 (US$ Bn)

11. Latin America Poultry Vaccines Market Analysis
11.1. Latin America Poultry Vaccines Market, by Application, 2017-2030(US$ Bn)
11.1.1. Overview
11.1.2. SRC Analysis
11.2. Latin America Poultry Vaccines Market, by Product, 2017-2030(US$ Bn)
11.2.1. Overview
11.2.2. SRC Analysis
11.3. Latin America Poultry Vaccines Market, by Disease Type, 2017-2030(US$ Bn)
11.3.1. Overview
11.3.2. SRC Analysis
11.4. Latin America Poultry Vaccines Market, by Country, 2017-2030 (US$ Bn)
11.4.1. Brazil
11.4.1.1. Brazil Poultry Vaccines Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.4.1.2. Brazil Poultry Vaccines, By Application, 2017-2030 (US$ Bn)
11.4.1.3. Brazil Poultry Vaccines, By Product, 2017-2030 (US$ Bn)
11.4.1.4. Brazil Poultry Vaccines, By Disease Type, 2017-2030 (US$ Bn)
11.4.2. Mexico
11.4.2.1. Mexico Poultry Vaccines Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.4.2.2. Mexico Poultry Vaccines, By Application, 2017-2030 (US$ Bn)
11.4.2.3. Mexico Poultry Vaccines, By Product, 2017-2030 (US$ Bn)
11.4.2.4. Mexico Poultry Vaccines, By Disease Type, 2017-2030 (US$ Bn)
11.4.3. Rest of Latin America
11.4.3.1. Rest of Latin America Poultry Vaccines Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.4.3.2. Rest of Latin America Poultry Vaccines, By Application, 2017-2030 (US$ Bn)
11.4.3.3. Rest of Latin America Poultry Vaccines, By Product, 2017-2030 (US$ Bn)
11.4.3.4. Rest of Latin America Poultry Vaccines, By Disease Type, 2017-2030 (US$ Bn)

12. Middle East and Africa Poultry Vaccines Market Analysis
12.1. Middle East and Africa Poultry Vaccines Market, by Application, 2017-2030(US$ Bn)
12.1.1. Overview
12.1.2. SRC Analysis
12.2. Middle East and Africa Poultry Vaccines Market, by Product, 2017-2030(US$ Bn)
12.2.1. Overview
12.2.2. SRC Analysis
12.3. Middle East and Africa Poultry Vaccines Market, by Disease Type, 2017-2030(US$ Bn)
12.3.1. Overview
12.3.2. SRC Analysis
12.4. Middle East and Africa Poultry Vaccines Market, by Country, 2017-2030 (US$ Bn)
12.4.1. GCC Countries
12.4.1.1. GCC Countries Poultry Vaccines Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.4.1.2. GCC Countries Poultry Vaccines, By Application, 2017-2030 (US$ Bn)
12.4.1.3. GCC Countries Poultry Vaccines, By Product, 2017-2030 (US$ Bn)
12.4.1.4. GCC Countries Poultry Vaccines, By Disease Type, 2017-2030 (US$ Bn)
12.4.2. South Africa
12.4.2.1. South Africa Poultry Vaccines Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.4.2.2. South Africa Poultry Vaccines, By Application, 2017-2030 (US$ Bn)
12.4.2.3. South Africa Poultry Vaccines, By Product, 2017-2030 (US$ Bn)
12.4.2.4. South Africa Poultry Vaccines, By Disease Type, 2017-2030 (US$ Bn)
12.4.3. Rest of Middle East and Africa
12.4.3.1. Rest of Middle East and Africa Poultry Vaccines Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.4.3.2. Rest of Middle East and Africa Poultry Vaccines, By Application, 2017-2030 (US$ Bn)
12.4.3.3. Rest of Middle East and Africa Poultry Vaccines, By Product, 2017-2030 (US$ Bn)
12.4.3.4. Rest of Middle East and Africa Poultry Vaccines, By Disease Type, 2017-2030 (US$ Bn)

13. Company Profiles
13.1. Boehringer Ingelheim International GmbH
13.1.1. Company Overview
13.1.2. Products/Services Portfolio
13.1.3. Geographical Presence
13.1.4. Financial Summary
13.1.4.1. Market Revenue and Net Profit (2019-2022)
13.1.4.2. Business Segment Revenue Analysis
13.1.4.3. Geographical Revenue Analysis
13.2. Ceva
13.3. Zoetis
13.4. Elanco
13.5. Intervet Inc., a Subsdiairy of Merck & Co., Inc.
13.6. Hester Biosciences Limited
13.7. Vaxxinova International BV
13.8. Venkys India
13.9. Calier
13.10. KM Biologics
13.11. Phibro Animal Health Corporation

List of Figures
FIG. 1 Global Poultry Vaccines Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Poultry Vaccines Market Segmentation
FIG. 4 Global Poultry Vaccines Market, by Application, 2022 (US$ Bn)
FIG. 5 Global Poultry Vaccines Market, by Product, 2022 (US$ Bn)
FIG. 6 Global Poultry Vaccines Market, by Disease Type, 2022 (US$ Bn)
FIG. 7 Global Poultry Vaccines Market, by Geography, 2022 (US$ Bn)
FIG. 8 Attractive Investment Proposition, by Application, 2022
FIG. 9 Attractive Investment Proposition, by Product, 2022
FIG. 10 Attractive Investment Proposition, by Disease Type, 2022
FIG. 11 Attractive Investment Proposition, by Geography, 2022
FIG. 12 Global Market Share Analysis of Key Poultry Vaccines Market Manufacturers, 2022
FIG. 13 Global Market Positioning of Key Poultry Vaccines Market Manufacturers, 2022
FIG. 14 Global Poultry Vaccines Market Value Contribution, By Application, 2022 & 2030 (Value %)
FIG. 15 Global Poultry Vaccines Market, by Broiler, Value, 2017-2030 (US$ Bn)
FIG. 16 Global Poultry Vaccines Market, by Layer, Value, 2017-2030 (US$ Bn)
FIG. 17 Global Poultry Vaccines Market, by Breeder, Value, 2017-2030 (US$ Bn)
FIG. 18 Global Poultry Vaccines Market Value Contribution, By Product, 2022 & 2030 (Value %)
FIG. 19 Global Poultry Vaccines Market, by Attenuated Live Vaccines, Value, 2017-2030 (US$ Bn)
FIG. 20 Global Poultry Vaccines Market, by Broiler, 2017-2030 (US$ Bn)
FIG. 21 Global Poultry Vaccines Market, by Lay Vaccines, 2017-2030 (US$ Bn)
FIG. 22 Global Poultry Vaccines Market, by Subunit Vaccines, 2017-2030 (US$ Bn)
FIG. 23 Global Poultry Vaccines Market, by DNA Vaccines, 2017-2030 (US$ Bn)
FIG. 24 Global Poultry Vaccines Market, by Recombinant Vaccines, 2017-2030 (US$ Bn)
FIG. 25 Global Poultry Vaccines Market Value Contribution, By Disease Type, 2022 & 2030 (Value %)
FIG. 26 Global Poultry Vaccines Market, by Infectious Bronchitis, Value, 2017-2030 (US$ Bn)
FIG. 27 Global Poultry Vaccines Market, by Infectious Bursal Diseases, 2017-2030 (US$ Bn)
FIG. 28 Global Poultry Vaccines Market, by Infectious Laryngotracheitis, 2017-2030 (US$ Bn)
FIG. 29 Global Poultry Vaccines Market, by Egg Drop Syndrome, 2017-2030 (US$ Bn)
FIG. 30 Global Poultry Vaccines Market, by Adenovirus, 2017-2030 (US$ Bn)
FIG. 31 Global Poultry Vaccines Market, by Duck Viral Enteritis, 2017-2030 (US$ Bn)
FIG. 32 Global Poultry Vaccines Market, by Inclusion Body Hepatitis, 2017-2030 (US$ Bn)
FIG. 33 Global Poultry Vaccines Market, by Coccidiosis, 2017-2030 (US$ Bn)
FIG. 34 Global Poultry Vaccines Market, by Avian Influenza, 2017-2030 (US$ Bn)
FIG. 35 Global Poultry Vaccines Market, by Marek’s Disease, 2017-2030 (US$ Bn)
FIG. 36 Global Poultry Vaccines Market, by Newcastle Disease, 2017-2030 (US$ Bn)
FIG. 37 Global Poultry Vaccines Market, by Salmonella, 2017-2030 (US$ Bn)
FIG. 38 Global Poultry Vaccines Market, by Avian Encephalomyelitis, 2017-2030 (US$ Bn)
FIG. 39 Global Poultry Vaccines Market, by Fowl Cholera, 2017-2030 (US$ Bn)
FIG. 40 North America Poultry Vaccines Market, 2017-2030 (US$ Bn)
FIG. 41 U.S. Poultry Vaccines Market, 2017-2030 (US$ Bn)
FIG. 42 Canada Poultry Vaccines Market, 2017-2030 (US$ Bn)
FIG. 43 Europe Poultry Vaccines Market, 2017-2030 (US$ Bn)
FIG. 44 Germany Poultry Vaccines Market, 2017-2030 (US$ Bn)
FIG. 45 France Poultry Vaccines Market, 2017-2030 (US$ Bn)
FIG. 46 U.K. Poultry Vaccines Market, 2017-2030 (US$ Bn)
FIG. 47 Italy Poultry Vaccines Market, 2017-2030 (US$ Bn)
FIG. 48 Spain Poultry Vaccines Market, 2017-2030 (US$ Bn)
FIG. 49 Rest of Europe Poultry Vaccines Market, 2017-2030 (US$ Bn)
FIG. 50 Asia Pacific Poultry Vaccines Market, 2017-2030 (US$ Bn)
FIG. 51 China Poultry Vaccines Market, 2017-2030 (US$ Bn)
FIG. 52 Japan Poultry Vaccines Market, 2017-2030 (US$ Bn)
FIG. 53 India Poultry Vaccines Market, 2017-2030 (US$ Bn)
FIG. 54 South Korea Poultry Vaccines Market, 2017-2030 (US$ Bn)
FIG. 55 South-East Asia Poultry Vaccines Market, 2017-2030 (US$ Bn)
FIG. 56 Rest of Asia Pacific Poultry Vaccines Market, 2017-2030 (US$ Bn)
FIG. 57 Latin America Poultry Vaccines Market, 2017-2030 (US$ Bn)
FIG. 58 Brazil Poultry Vaccines Market, 2017-2030 (US$ Bn)
FIG. 59 Mexico Poultry Vaccines Market, 2017-2030 (US$ Bn)
FIG. 60 Rest of Latin America Poultry Vaccines Market, 2017-2030 (US$ Bn)
FIG. 61 Middle East & Africa Poultry Vaccines Market, 2017-2030 (US$ Bn)
FIG. 62 GCC Countries Poultry Vaccines Market, 2017-2030 (US$ Bn)
FIG. 63 South Africa Poultry Vaccines Market, 2017-2030 (US$ Bn)
FIG. 64 Rest of Middle East and Africa Poultry Vaccines Market, 2017-2030 (US$ Bn)

List of Tables
TABLE 1 Market Snapshot: Global Poultry Vaccines Market
TABLE 2 Global Poultry Vaccines Market, by Competitive Benchmarking, 2022
TABLE 3 Global Poultry Vaccines Market, by Geographical Presence Analysis, 2022
TABLE 4 Global Poultry Vaccines Market, by Key Strategies Analysis, 2022
TABLE 5 Global Poultry Vaccines Market, by Application, 2017-2030 (US$ Bn)
TABLE 6 Global Poultry Vaccines Market, by Product, 2017-2030 (US$ Bn)
TABLE 7 Global Poultry Vaccines Market, by Disease Type, 2017-2030 (US$ Bn)
TABLE 8 Global Poultry Vaccines Market, by Geography, 2017-2030 (US$ Bn)
TABLE 9 North America Poultry Vaccines Market, by Application, 2017-2030 (US$ Bn)
TABLE 10 North America Poultry Vaccines Market, by Product, 2017-2030 (US$ Bn)
TABLE 11 North America Poultry Vaccines Market, by Disease Type, 2017-2030 (US$ Bn)
TABLE 12 North America Poultry Vaccines Market, by Country, 2017-2030 (US$ Bn)
TABLE 13 US Poultry Vaccines Market, by Application, 2017-2030 (US$ Bn)
TABLE 14 US Poultry Vaccines Market, by Product, 2017-2030 (US$ Bn)
TABLE 15 US Poultry Vaccines Market, by Disease Type, 2017-2030 (US$ Bn)
TABLE 16 Canada Poultry Vaccines Market, by Application, 2017-2030 (US$ Bn)
TABLE 17 Canada Poultry Vaccines Market, by Product, 2017-2030 (US$ Bn)
TABLE 18 Canada Poultry Vaccines Market, by Disease Type, 2017-2030 (US$ Bn)
TABLE 19 Europe Poultry Vaccines Market, by Application, 2017-2030 (US$ Bn)
TABLE 20 Europe Poultry Vaccines Market, by Product, 2017-2030 (US$ Bn)
TABLE 21 Europe Poultry Vaccines Market, by Disease Type, 2017-2030 (US$ Bn)
TABLE 22 Europe Poultry Vaccines Market, by Country, 2017-2030 (US$ Bn)
TABLE 23 Germany Poultry Vaccines Market, by Application, 2017-2030 (US$ Bn)
TABLE 24 Germany Poultry Vaccines Market, by Product, 2017-2030 (US$ Bn)
TABLE 25 Germany Poultry Vaccines Market, by Disease Type, 2017-2030 (US$ Bn)
TABLE 26 France Poultry Vaccines Market, by Application, 2017-2030 (US$ Bn)
TABLE 27 France Poultry Vaccines Market, by Product, 2017-2030 (US$ Bn)
TABLE 28 France Poultry Vaccines Market, by Disease Type, 2017-2030 (US$ Bn)
TABLE 29 UK Poultry Vaccines Market, by Application, 2017-2030 (US$ Bn)
TABLE 30 UK Poultry Vaccines Market, by Product, 2017-2030 (US$ Bn)
TABLE 31 UK Poultry Vaccines Market, by Disease Type, 2017-2030 (US$ Bn)
TABLE 32 Italy Poultry Vaccines Market, by Application, 2017-2030 (US$ Bn)
TABLE 33 Italy Poultry Vaccines Market, by Product, 2017-2030 (US$ Bn)
TABLE 34 Italy Poultry Vaccines Market, by Disease Type, 2017-2030 (US$ Bn)
TABLE 35 Spain Poultry Vaccines Market, by Application, 2017-2030 (US$ Bn)
TABLE 36 Spain Poultry Vaccines Market, by Product, 2017-2030 (US$ Bn)
TABLE 37 Spain Poultry Vaccines Market, by Disease Type, 2017-2030 (US$ Bn)
TABLE 38 Rest of Europe Poultry Vaccines Market, by Application, 2017-2030 (US$ Bn)
TABLE 39 Rest of Europe Poultry Vaccines Market, by Product, 2017-2030 (US$ Bn)
TABLE 40 Rest of Europe Poultry Vaccines Market, by Disease Type, 2017-2030 (US$ Bn)
TABLE 41 Asia Pacific Poultry Vaccines Market, by Application, 2017-2030 (US$ Bn)
TABLE 42 Asia Pacific Poultry Vaccines Market, by Product, 2017-2030 (US$ Bn)
TABLE 43 Asia Pacific Poultry Vaccines Market, by Disease Type, 2017-2030 (US$ Bn)
TABLE 44 Asia Pacific Poultry Vaccines Market, by Country, 2017-2030 (US$ Bn)
TABLE 45 China Poultry Vaccines Market, by Application, 2017-2030 (US$ Bn)
TABLE 46 China Poultry Vaccines Market, by Product, 2017-2030 (US$ Bn)
TABLE 47 China Poultry Vaccines Market, by Disease Type, 2017-2030 (US$ Bn)
TABLE 48 Japan Poultry Vaccines Market, by Application, 2017-2030 (US$ Bn)
TABLE 49 Japan Poultry Vaccines Market, by Product, 2017-2030 (US$ Bn)
TABLE 50 Japan Poultry Vaccines Market, by Disease Type, 2017-2030 (US$ Bn)
TABLE 51 India Poultry Vaccines Market, by Application, 2017-2030 (US$ Bn)
TABLE 52 India Poultry Vaccines Market, by Product, 2017-2030 (US$ Bn)
TABLE 53 India Poultry Vaccines Market, by Disease Type, 2017-2030 (US$ Bn)
TABLE 54 South Korea Poultry Vaccines Market, by Application, 2017-2030 (US$ Bn)
TABLE 55 South Korea Poultry Vaccines Market, by Product, 2017-2030 (US$ Bn)
TABLE 56 South Korea Poultry Vaccines Market, by Disease Type, 2017-2030 (US$ Bn)
TABLE 57 South-East Asia Poultry Vaccines Market, by Application, 2017-2030 (US$ Bn)
TABLE 58 South-East Asia Poultry Vaccines Market, by Product, 2017-2030 (US$ Bn)
TABLE 59 South-East Asia Poultry Vaccines Market, by Disease Type, 2017-2030 (US$ Bn)
TABLE 60 Rest of Asia Pacific Poultry Vaccines Market, by Application, 2017-2030 (US$ Bn)
TABLE 61 Rest of Asia Pacific Poultry Vaccines Market, by Product, 2017-2030 (US$ Bn)
TABLE 62 Rest of Asia Pacific Poultry Vaccines Market, by Disease Type, 2017-2030 (US$ Bn)
TABLE 63 Latin America Poultry Vaccines Market, by Application, 2017-2030 (US$ Bn)
TABLE 64 Latin America Poultry Vaccines Market, by Product, 2017-2030 (US$ Bn)
TABLE 65 Latin America Poultry Vaccines Market, by Disease Type, 2017-2030 (US$ Bn)
TABLE 66 Latin America Poultry Vaccines Market, by Country, 2017-2030 (US$ Bn)
TABLE 67 Brazil Poultry Vaccines Market, by Application, 2017-2030 (US$ Bn)
TABLE 68 Brazil Poultry Vaccines Market, by Product, 2017-2030 (US$ Bn)
TABLE 69 Brazil Poultry Vaccines Market, by Disease Type, 2017-2030 (US$ Bn)
TABLE 70 Mexico Poultry Vaccines Market, by Application, 2017-2030 (US$ Bn)
TABLE 71 Mexico Poultry Vaccines Market, by Product, 2017-2030 (US$ Bn)
TABLE 72 Mexico Poultry Vaccines Market, by Disease Type, 2017-2030 (US$ Bn)
TABLE 73 Rest of Latin America Poultry Vaccines Market, by Application, 2017-2030 (US$ Bn)
TABLE 74 Rest of Latin America Poultry Vaccines Market, by Product, 2017-2030 (US$ Bn)
TABLE 75 Rest of Latin America Poultry Vaccines Market, by Disease Type, 2017-2030 (US$ Bn)
TABLE 76 Middle East and Africa Poultry Vaccines Market, by Application, 2017-2030 (US$ Bn)
TABLE 77 Middle East and Africa Poultry Vaccines Market, by Product, 2017-2030 (US$ Bn)
TABLE 78 Middle East and Africa Poultry Vaccines Market, by Disease Type, 2017-2030 (US$ Bn)
TABLE 79 Middle East and Africa Poultry Vaccines Market, by Country, 2017-2030 (US$ Bn)
TABLE 80 GCC Countries Poultry Vaccines Market, by Application, 2017-2030 (US$ Bn)
TABLE 81 GCC Countries Poultry Vaccines Market, by Product, 2017-2030 (US$ Bn)
TABLE 82 GCC Countries Poultry Vaccines Market, by Disease Type, 2017-2030 (US$ Bn)
TABLE 83 South Africa Poultry Vaccines Market, by Application, 2017-2030 (US$ Bn)
TABLE 84 South Africa Poultry Vaccines Market, by Product, 2017-2030 (US$ Bn)
TABLE 85 South Africa Poultry Vaccines Market, by Disease Type, 2017-2030 (US$ Bn)
TABLE 86 Rest of Middle East and Africa Poultry Vaccines Market, by Application, 2017-2030 (US$ Bn)
TABLE 87 Rest of Middle East and Africa Poultry Vaccines Market, by Product, 2017-2030 (US$ Bn)
TABLE 88 Rest of Middle East and Africa Poultry Vaccines Market, by Disease Type, 2017-2030 (US$ Bn)

Frequently asked questions

How does COVID-19 Impact the global poultry vaccines market?

COVID-19 has had a significant impact on the poultry vaccines market.

Which is the leading region of the market for poultry vaccines?

North America accounted for the most heightened share in the global poultry vaccines market.

What are the key drivers for the growth of the poultry vaccines market?

Global zoonotic disease incidence is expected to rise, propelling market expansion.

Which is the major segment in the poultry vaccines market by application?

The breeder segment had a major share in the global market in 2022.

Which is the major segment in the poultry vaccines market by disease type?

The infectious bronchitis segment had a major share in the global market.

Purchase Options

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –